文献速递临床免疫临床微生物

Elecsys恰加斯检测在多中心研究中的性能评估

Evaluation of the Elecsys Chagas Assay for Detection of Trypanosoma cruzi-Specific Antibodies in a Multicenter Study in Europe and Latin America.
PubMed 文献 · J Clin Microbiol · 2018-04-25

该研究在欧洲和拉丁美洲多中心评估Elecsys恰加斯检测(双抗原夹心法)检测克氏锥虫特异性抗体的性能。对674例样本相对灵敏度为100%,对血友、孕妇和住院患者样本相对特异性分别为99.90%(n=14,681)、100%(n=313)和100%(n=517)。分析特异性99.83%(n=594),可在WHO参考品1:512稀释下检出抗体,对应 cutoff 灵敏度约1 mIU/ml。

要点

  • Elecsys恰加斯检测总体相对灵敏度100%(n=674),相对特异性高。
  • 血友样本相对特异性99.90%(n=14,681),孕妇和住院患者均为100%。
  • 分析特异性99.83%(n=594),交叉反应少。

核心结论

  • Elecsys恰加斯检测在欧洲和拉美多中心常规条件下表现出稳健性能,灵敏度高且分析特异性改善。

研究设计与样本

  • 多中心评估研究,在欧洲和拉丁美洲多个站点比较Elecsys恰加斯检测与其他常用克氏锥虫抗体检测。
  • 样本来自流行区和非流行区的血友、孕妇及住院患者,用于评估相对灵敏度和特异性。

主要发现

  • 总体相对灵敏度为100%(n=674)。
  • 血友样本总体相对特异性为99.90%(n=14,681)。
  • 孕妇样本总体相对特异性为100%(n=313)。
  • 住院患者样本总体相对特异性为100%(n=517)。
  • 分析特异性为99.83%(n=594)。

关键数值与推荐

  • 在WHO标准克氏锥虫参考品(panels 09/188和09/186)1:512稀释下检出抗体,对应 cutoff 灵敏度约1 mIU/ml。
  • 该检测使用较少的重组克氏锥虫抗原,交叉反应显著减少,分析特异性提高。

临床怎么用

  • 可用于恰加斯病诊断和血友筛查,在流行区和非流行区多站点常规条件下性能稳健。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Serology is the preferred method to confirm a Chagas disease diagnosis and to screen blood donors. A battery of assays is often required due to the limited accuracy of single assays. The Elecsys Chagas assay is a newly developed, double-antigen sandwich assay for use on the Elecsys and cobas e immunoassay analyzers, intended to identify individuals infected with Trypanosoma cruzi, for diagnosis and screening. The performance of the Elecsys Chagas assay was evaluated in comparison with those of other widely used T. cruzi antibody assays, at multiple sites (Europe/Latin America). Relative sensitivity and specificity were assessed by using samples from blood donors, pregnant women, and hospitalized patients from regions where Chagas disease is endemic and from regions of nonendemicity. The Elecsys Chagas assay had an overall relative sensitivity of 100% (n = 674). Overall relative specificities were 99.90% (n = 14,681), 100% (n = 313), and 100% (n = 517) for samples from blood donors, pregnant women, and hospitalized patients, respectively. The analytical specificity was 99.83% (n = 594). The Elecsys Chagas assay detected T. cruzi antibodies in two World Health Organization (WHO) standard T. cruzi reference panels (panels 09/188 and 09/186) at a 1:512 dilution, corresponding to a cutoff sensitivity of approximately 1 mIU/ml. The Elecsys Chagas assay demonstrated robust performance under routine conditions at multiple sites in Europe and Latin America. In contrast to other available Chagas assays, the Elecsys assay uses a reduced number of recombinant T. cruzi antigens, resulting in a significantly smaller number of cross-reactions and improved analytical specificity while being highly sensitive.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Flores-Chavez MD, Sambri V, Schottstedt V, et al. Evaluation of the Elecsys Chagas Assay for Detection of Trypanosoma cruzi-Specific Antibodies in a Multicenter Study in Europe and Latin America. J Clin Microbiol. 2018. PMID: 29444836. doi:10.1128/JCM.01446-17

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。